Search
40 hits for Test within The Public Health Agency of Sweden
-
Barriers and motivating factors to MMR vaccination in communities with low coverage in Sweden
Published:The report presents results from a pilot test of Tailoring Immunization Programmes (TIP), a method developed by WHO/Europe to identify barriers and motivating factors to MMR vaccination in communities with low coverage in Sweden.
-
Information about sales of tobacco-free nicotine products to consumers
Published:The information sheet summarises certain provisions that apply to the sale of tobacco-free nicotine products. It is important that you as a retailer know all the rules that apply to your business.
-
Information about the sale of electronic cigarettes and refill containers to consumers
Published:This information sheet is intended for those who sell or intend to start selling electronic cigarettes and refill containers to consumers (retailers).
-
Catch up vaccinations
Updated:Guidelines for children who have started vaccinations in other countries and children born in Sweden who have not followed the regular programme.
-
For individuals who have earned qualifications from another EU or EEA member state
Updated:The professional use of Class 1 and 2 plant protection products and Class 1 biocide products within Swedish Public Health Agency areas of responsibility are in the form of regulated professions, consequently Swedish legislation regulates what is required for such use.
-
Availability to antibiotics of particular importance – A Swedish pilot study of an alternative reimbursement model
Published:Updated:In a pilot project, the Public Health Agency of Sweden has investigated whether a model with guaranteed reimbursement to the pharmaceutical company can improve access to particularly important antibiotics in Sweden. An initial evaluation shows that the studied reimbursement model led to increased
-
Protection by a third and fourth dose of vaccine against COVID-19 among persons aged 65 years and older – Based on Swedish data from February to August 2022
Published:This report presents an analysis of COVID-19 vaccine effectiveness (VE) after a fourth dose in relation to SARS-CoV-2 infection and severe outcomes due to the omicron variant among persons aged 65 years and older in Sweden.
-
Methods and analysis of the long-term follow up of the effectiveness of one whole cell and two acellular pertussis vaccines
Published:Since 1997, the Public Health Agency of Sweden has conducted an Enhanced pertussis surveillance (EPS) of children with pertussis in Sweden. Part of the surveillance includes clinical information and vaccination histories. The methods used in the article are described in more detail in this
-
Availability of antibiotics
Updated:Antibiotics must be used responsibly and the availability of antibiotics of special medical value must be safeguarded. The Government has commissioned the Public Health Agency of Sweden (PHAS) to propose and pilot new models for keeping approved antibiotics available on the Swedish market.
-
Questions_answers_Agreements_signed_pilot_study_new_reimbursement_model.pdf
Published:Solna Folkhälsomyndigheten, SE-171 82 Solna. Street address: Nobels väg 18. Östersund Folkhälsomyndigheten, Box 505, 831 26 Östersund. Street address: Campusvägen 20. +46 10-205 20 00, info@folkhalsomyndigheten.se, www.folkhalsomyndigheten.se Questions and answers – Agreements signed for a pilot